Cell Rep:揭示RNA剪接在阿尔茨海默症中的作用

2019-10-13 佚名 BioArt

pre-mRNA剪接过程是基因表达调控的重要步骤,对于形成极具多样性的神经细胞转录组尤为关键。因此,RNA 剪接失调能够引起包括脊髓性肌肉萎缩症和肌萎缩性脊髓侧索硬化症等多种神经疾病。2013年,美国Emory大学的Seyfried教授课题组发现RNA剪接失调可能也是引起阿尔兹海默症的原因之一。阿尔兹海默症是一种随时间不断恶化的神经退行性疾病,该疾病导致人的记忆和思考能力衰退,是世界上最常见的神经

pre-mRNA剪接过程是基因表达调控的重要步骤,对于形成极具多样性的神经细胞转录组尤为关键。因此,RNA 剪接失调能够引起包括脊髓性肌肉萎缩症和肌萎缩性脊髓侧索硬化症等多种神经疾病。2013年,美国Emory大学的Seyfried教授课题组发现RNA剪接失调可能也是引起阿尔兹海默症的原因之一。阿尔兹海默症是一种随时间不断恶化的神经退行性疾病,该疾病导致人的记忆和思考能力衰退,是世界上最常见的神经退行性疾病。然而,阿尔兹海默症的病理机制还不明确,目前也没有有效的治疗方法。

由A蛋白组成的细胞外斑块沉积和Tau蛋白组成的细胞内神经纤维缠结是阿尔兹海默症的两个决定性标志。Seyfried课题组利用先进的蛋白组学方法鉴定了患有阿尔兹海默症的人脑死亡标本的难溶蛋白组,其中包括A蛋白和Tau蛋白,以及多种RNA剪接体的核心成分。免疫组织学染色发现这些RNA剪接核心成分与Tau蛋白重叠,在阿尔兹海默症人脑中形成类似神经纤维缠结的结构。那么,RNA剪接失调是否与阿兹海默症的形成有关呢?

2019年10月8日,美国贝勒医学院Joshua Shulman教授课题组(共同一作为Yi-Chen Hsieh,郭采薇和Hari K Yalamanchili博士)在Cell Reports发表题为Tau-mediated Disruption of the Spliceosome Triggers Cryptic RNA-splicing and Neurodegeneration in Alzheimer’s Disease的文章,进一步揭示了RNA剪接在Tau蛋白引起的阿尔兹海默症重要影响。

与Seyfried课题组的进一步合作发现,在患有阿尔兹海默症的人脑死亡标本中可溶性Tau蛋白的免疫共沉淀蛋白组中同样存在多种RNA剪接体核心成分(U1A,U1-70K,SmB,SmD2,SmD3等)。结合之前的研究结果表明,可溶性的低聚物Tau蛋白和难溶性的纤维Tau蛋白都有可能与RNA剪接成分存在相互作用。接着,研究人员利用阿尔兹海默症Tau蛋白果蝇模型证实了多种RNA剪接体核心成分与Tau蛋白存在遗传相互作用。这种相互作用可能与RNA剪接体核心成分的合成能力或稳定性降低有关,因为在Tau蛋白果蝇模型中多种RNA剪接体核心成分的蛋白含量降低。

那么RNA剪接失调是否是引起神经退行性表型的充分条件呢?研究人员以RNA剪接体核心成分之一SmB为对象,生成了SmB突变果蝇,并检测了该果蝇的多种神经退行性相关表型,包括其生存能力降低、运动能力降低和神经细胞丢失,与阿尔兹海默症Tau蛋白果蝇模型非常相似。在SmB突变果蝇中恢复SmB的表达能够完全抑制上述神经退行性表型。

最后,研究人员利用深度RNA测序探索了阿尔兹海默症Tau蛋白果蝇模型转录组中是否存在剪接错误的情况。通过由贝勒医学院Liu教授课题组发明的新型生物信息学检测方法发现,Tau蛋白能够引起大量的随年龄和Tau蛋白毒性递增的剪接错误。对剪接错误的基因结构特性分析指出,Tau蛋白果蝇模型中的剪接错误和SmB突变果蝇中的剪接错误非常相似,表明Tau蛋白引起的剪接错误很可能由RNA剪接失活产生。同时,研究人员对上百个阿兹海默症人脑死亡标本的RNA测序转录组进行了生物信息学分析,进一步证实了剪接错误与Tau蛋白病理表现呈显着正相关。

总的来说,通过结合对阿兹海默症人脑死亡标本和果蝇模型的研究,这些发现揭示了一个由RNA剪接失调引起的阿兹海默症病理模型(下图)。简单来说,在阿兹海默症中可溶性或难溶性Tau蛋白与RNA剪接体的核心成分相互作用,影响RNA剪接体的正常功能,从而引起全转录组范围的大量剪接错误,最终导致神经细胞丢失以及各种神经退行性表型。该研究不仅生成了新的RNA剪接相关果蝇模型,发明了新的RNA剪接生物信息学检测方法,更为阿兹海默症的病理研究和临床治疗提供了新的思路。

原始出处
Yi-ChenHsieh,CaiweiGuo,Hari K.Ya,et al.Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer’s Disease.cell rep.Volume 29, Issue 2, 8 October 2019, Pages 301-316.e10https://doi.org/10.1016/j.celrep.2019.08.104

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1961734, encodeId=2f791961e3484, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Jun 08 16:03:00 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642600, encodeId=07a916426001e, content=<a href='/topic/show?id=ad8815553d4' target=_blank style='color:#2F92EE;'>#RNA剪接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15553, encryptionId=ad8815553d4, topicName=RNA剪接)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6422977573, createdName=12498ebem26暂无昵称, createdTime=Tue Jun 09 23:03:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1816946, encodeId=0a2518169464d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sat Jul 25 02:03:00 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871448, encodeId=7abc18e144894, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 05 16:03:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817969, encodeId=4c06181e969c3, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 22 18:03:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470323, encodeId=81dc14e032347, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Oct 15 11:03:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]
    2020-06-08 维他命
  2. [GetPortalCommentsPageByObjectIdResponse(id=1961734, encodeId=2f791961e3484, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Jun 08 16:03:00 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642600, encodeId=07a916426001e, content=<a href='/topic/show?id=ad8815553d4' target=_blank style='color:#2F92EE;'>#RNA剪接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15553, encryptionId=ad8815553d4, topicName=RNA剪接)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6422977573, createdName=12498ebem26暂无昵称, createdTime=Tue Jun 09 23:03:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1816946, encodeId=0a2518169464d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sat Jul 25 02:03:00 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871448, encodeId=7abc18e144894, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 05 16:03:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817969, encodeId=4c06181e969c3, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 22 18:03:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470323, encodeId=81dc14e032347, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Oct 15 11:03:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1961734, encodeId=2f791961e3484, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Jun 08 16:03:00 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642600, encodeId=07a916426001e, content=<a href='/topic/show?id=ad8815553d4' target=_blank style='color:#2F92EE;'>#RNA剪接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15553, encryptionId=ad8815553d4, topicName=RNA剪接)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6422977573, createdName=12498ebem26暂无昵称, createdTime=Tue Jun 09 23:03:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1816946, encodeId=0a2518169464d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sat Jul 25 02:03:00 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871448, encodeId=7abc18e144894, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 05 16:03:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817969, encodeId=4c06181e969c3, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 22 18:03:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470323, encodeId=81dc14e032347, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Oct 15 11:03:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1961734, encodeId=2f791961e3484, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Jun 08 16:03:00 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642600, encodeId=07a916426001e, content=<a href='/topic/show?id=ad8815553d4' target=_blank style='color:#2F92EE;'>#RNA剪接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15553, encryptionId=ad8815553d4, topicName=RNA剪接)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6422977573, createdName=12498ebem26暂无昵称, createdTime=Tue Jun 09 23:03:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1816946, encodeId=0a2518169464d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sat Jul 25 02:03:00 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871448, encodeId=7abc18e144894, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 05 16:03:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817969, encodeId=4c06181e969c3, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 22 18:03:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470323, encodeId=81dc14e032347, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Oct 15 11:03:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1961734, encodeId=2f791961e3484, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Jun 08 16:03:00 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642600, encodeId=07a916426001e, content=<a href='/topic/show?id=ad8815553d4' target=_blank style='color:#2F92EE;'>#RNA剪接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15553, encryptionId=ad8815553d4, topicName=RNA剪接)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6422977573, createdName=12498ebem26暂无昵称, createdTime=Tue Jun 09 23:03:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1816946, encodeId=0a2518169464d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sat Jul 25 02:03:00 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871448, encodeId=7abc18e144894, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 05 16:03:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817969, encodeId=4c06181e969c3, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 22 18:03:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470323, encodeId=81dc14e032347, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Oct 15 11:03:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1961734, encodeId=2f791961e3484, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Jun 08 16:03:00 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642600, encodeId=07a916426001e, content=<a href='/topic/show?id=ad8815553d4' target=_blank style='color:#2F92EE;'>#RNA剪接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15553, encryptionId=ad8815553d4, topicName=RNA剪接)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6422977573, createdName=12498ebem26暂无昵称, createdTime=Tue Jun 09 23:03:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1816946, encodeId=0a2518169464d, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sat Jul 25 02:03:00 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871448, encodeId=7abc18e144894, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 05 16:03:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817969, encodeId=4c06181e969c3, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 22 18:03:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470323, encodeId=81dc14e032347, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Oct 15 11:03:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]

相关资讯

Blood:SKI可调控MDS相关的慢性TGFβ信号、RNA异常剪接和干细胞适应性

中心点:Ski对造血干细胞的正常适应性至关重要,其可抑制TGFβ信号和异常RNA剪接。部分骨髓增生异常患者可见miR-21导致SKI缺失,进而激活TGFβ信号、促进RNA异常剪接。摘要:转化生长因子β(TGFβ)信号通路调控造血干细胞(HSC)在骨髓壁龛中的表现;但在骨髓增生异常综合征(MDS)早期,TGFβ信号缓慢变化。TGFβ信号通常是诱导负反馈,但在MDS早期,高miR-21水平可促进慢性T

Genes Dev:徐永镇研究组揭示肿瘤细胞SF3B1突变导致RNA剪接紊乱的分子机制

作为RNA加工过程的关键步骤,RNA剪接的精确性是基因得以正常表达的先决条件之一,RNA剪接异常导致的基因表达紊乱是多种疾病发生的重要原因。近年来,高通量测序技术检测发现各类肿瘤细胞中存在多种剪接因子突变,这些突变均不同程度地影响了RNA剪接,导致下游基因表达异常。SF3B1/Hsh155是早期剪接体组装过程中的关键因子,在多种肿瘤细胞中都出现了较高频率的突变,其中以骨髓发育异常综合征(MDS)和

Nature:如山铁证——衰老与RNA剪接的关系

衰老是慢性疾病和各种毁灭性疾病的关键风险因素,但是,随着时间的推移,人们对于细胞是从什么时候开始以及如何走向衰亡的生物影响因素仍然存留着大片的空白。如今,由哈佛陈曾熙公共卫生学院组建的研究小组首次显示出了细胞这一“机器”的核心组件——RNA剪接,它是剪切和拼接RNA分子的过程。而这一核心组件与细胞和人体的衰老有着重要关系。为弄清二者之间的关系,该研究小组通过利用秀丽隐杆线虫来探讨剪切与衰老之间的潜